- €29.47m
- €310.26m
- €98.01m
- 26
- 93
- 15
- 38
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 180 | 216 | 15.4 | 44.9 | 98 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 148 | 172 | 40.7 | 43 | 88.7 |
Operating Profit | 32 | 43.8 | -25.3 | 1.91 | 9.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 29.7 | 23.1 | 42.2 | -12.9 | -6.24 |
Provision for Income Taxes | |||||
Net Income After Taxes | 30.2 | 18.2 | 43.2 | -9.74 | -8.89 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 30.2 | 18.2 | 12.8 | -30.3 | -8.88 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 30.2 | 18.2 | 12.8 | -30.3 | -8.88 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.078 | 0.034 | -0.033 | -0.032 | -0.019 |
Dividends per Share |